Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
1.070
-0.070 (-6.14%)
Jul 9, 2026, 3:43 PM EST
BCLI Market Cap
BCLI has a market cap or net worth of $11.81 million as of July 10, 2026. Its market cap has increased by 20.92% in one year.
Market Cap
11.81M
Enterprise Value
13.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.07
Market Cap Chart
Since May 28, 2003, BCLI's market cap has increased from 454.50K to 11.81M, an increase of 2,497.87%. That is a compound annual growth rate of 15.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 11.81M | 93.49% |
| Dec 31, 2025 | 6.10M | -52.87% |
| Dec 31, 2024 | 12.95M | -3.18% |
| Dec 29, 2023 | 13.37M | -77.69% |
| Dec 30, 2022 | 59.93M | -58.70% |
| Dec 31, 2021 | 145.11M | 1.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oncotelic Therapeutics | 17.60M |
| Finch Therapeutics Group | 16.86M |
| Zenith Capital | 15.97M |
| Nymox Pharmaceutical | 14.29M |
| Galera Therapeutics | 14.28M |
| Anebulo Pharmaceuticals | 13.94M |
| Zeo ScientifiX | 13.85M |
| Inhibitor Therapeutics | 13.64M |